BSGM
Price
$10.41
Change
+$0.76 (+7.88%)
Updated
Jul 3 closing price
Capitalization
6.17M
MASI
Price
$167.57
Change
-$3.77 (-2.20%)
Updated
Jul 3 closing price
Capitalization
7.66B
38 days until earnings call
Interact to see
Advertisement

BSGM vs MASI

Header iconBSGM vs MASI Comparison
Open Charts BSGM vs MASIBanner chart's image
BioSig Technologies
Price$10.41
Change+$0.76 (+7.88%)
Volume$720.63K
Capitalization6.17M
Masimo
Price$167.57
Change-$3.77 (-2.20%)
Volume$498.67K
Capitalization7.66B
BSGM vs MASI Comparison Chart in %
Loading...
BSGM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSGM vs. MASI commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSGM is a Buy and MASI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (BSGM: $10.41 vs. MASI: $167.57)
Brand notoriety: BSGM and MASI are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BSGM: 79% vs. MASI: 76%
Market capitalization -- BSGM: $6.17M vs. MASI: $7.66B
BSGM [@Medical Specialties] is valued at $6.17M. MASI’s [@Medical Specialties] market capitalization is $7.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSGM’s FA Score shows that 0 FA rating(s) are green whileMASI’s FA Score has 1 green FA rating(s).

  • BSGM’s FA Score: 0 green, 5 red.
  • MASI’s FA Score: 1 green, 4 red.
According to our system of comparison, MASI is a better buy in the long-term than BSGM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSGM’s TA Score shows that 4 TA indicator(s) are bullish while MASI’s TA Score has 7 bullish TA indicator(s).

  • BSGM’s TA Score: 4 bullish, 4 bearish.
  • MASI’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, MASI is a better buy in the short-term than BSGM.

Price Growth

BSGM (@Medical Specialties) experienced а +22.33% price change this week, while MASI (@Medical Specialties) price change was +0.52% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.95%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was -0.02%.

Reported Earning Dates

MASI is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Medical Specialties (+1.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MASI($7.66B) has a higher market cap than BSGM($6.17M). BSGM YTD gains are higher at: 598.658 vs. MASI (1.373). MASI has higher annual earnings (EBITDA): 237M vs. BSGM (-28.99M). MASI has more cash in the bank: 163M vs. BSGM (491K). BSGM has less debt than MASI: BSGM (532K) vs MASI (970M). MASI has higher revenues than BSGM: MASI (2.05B) vs BSGM (141K).
BSGMMASIBSGM / MASI
Capitalization6.17M7.66B0%
EBITDA-28.99M237M-12%
Gain YTD598.6581.37343,594%
P/E RatioN/A95.93-
Revenue141K2.05B0%
Total Cash491K163M0%
Total Debt532K970M0%
FUNDAMENTALS RATINGS
BSGM vs MASI: Fundamental Ratings
BSGM
MASI
OUTLOOK RATING
1..100
8717
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
3448
P/E GROWTH RATING
1..100
10017
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BSGM's Valuation (86) in the Medical Specialties industry is in the same range as MASI (90). This means that BSGM’s stock grew similarly to MASI’s over the last 12 months.

BSGM's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MASI (100). This means that BSGM’s stock grew similarly to MASI’s over the last 12 months.

MASI's SMR Rating (97) in the Medical Specialties industry is in the same range as BSGM (100). This means that MASI’s stock grew similarly to BSGM’s over the last 12 months.

BSGM's Price Growth Rating (34) in the Medical Specialties industry is in the same range as MASI (48). This means that BSGM’s stock grew similarly to MASI’s over the last 12 months.

MASI's P/E Growth Rating (17) in the Medical Specialties industry is significantly better than the same rating for BSGM (100). This means that MASI’s stock grew significantly faster than BSGM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSGMMASI
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
46%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
62%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
72%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
71%
Advances
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 4 days ago
70%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 10 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
68%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
BSGM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FCEL5.500.18
+3.38%
FuelCell Energy Inc
MIRM50.301.21
+2.46%
Mirum Pharmaceuticals
TTNP4.400.05
+1.15%
Titan Pharmaceuticals
TAP49.44-0.10
-0.20%
Molson Coors Beverage Company
CTNM3.88-0.12
-3.00%
Contineum Therapeutics

BSGM and

Correlation & Price change

A.I.dvisor tells us that BSGM and IRTC have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSGM and IRTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSGM
1D Price
Change %
BSGM100%
+7.88%
IRTC - BSGM
25%
Poorly correlated
-0.22%
BLFS - BSGM
23%
Poorly correlated
+0.40%
ISRG - BSGM
23%
Poorly correlated
+0.72%
MASI - BSGM
22%
Poorly correlated
-2.20%
PAVM - BSGM
22%
Poorly correlated
-3.08%
More

MASI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MASI has been loosely correlated with INSP. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MASI jumps, then INSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MASI
1D Price
Change %
MASI100%
-2.20%
INSP - MASI
46%
Loosely correlated
-1.71%
ISRG - MASI
46%
Loosely correlated
+0.72%
VCYT - MASI
44%
Loosely correlated
-0.25%
BSX - MASI
43%
Loosely correlated
-0.44%
MMSI - MASI
41%
Loosely correlated
+0.07%
More